193 related articles for article (PubMed ID: 27977885)
21. Outcomes of marginal donors for lung transplantation after ex vivo lung perfusion: A systematic review and meta-analysis.
Tian D; Wang Y; Shiiya H; Sun CB; Uemura Y; Sato M; Nakajima J
J Thorac Cardiovasc Surg; 2020 Feb; 159(2):720-730.e6. PubMed ID: 31548078
[TBL] [Abstract][Full Text] [Related]
22. First experience with ex vivo lung perfusion for initially discarded donor lungs in the Netherlands: a single-centre study.
Zhang ZL; van Suylen V; van Zanden JE; Van De Wauwer C; Verschuuren EAM; van der Bij W; Erasmus ME
Eur J Cardiothorac Surg; 2019 May; 55(5):920-926. PubMed ID: 30496383
[TBL] [Abstract][Full Text] [Related]
23. Peripheral Blood Gene Expression Changes Associated With Primary Graft Dysfunction After Lung Transplantation.
Diamond JM; Cantu E; Porteous MK; Suzuki Y; Meyer KC; Lederer DJ; Milewski RK; Arcasoy S; D'Ovidio F; Bacchetta M; Sonett JR; Singh G; Costa J; Tobias JW; Rodriguez H; Van Deerlin VM; Olthoff KM; Shaked A; Chang BL; Christie JD;
Am J Transplant; 2017 Jul; 17(7):1770-1777. PubMed ID: 28117940
[TBL] [Abstract][Full Text] [Related]
24. The role of the endothelin-1 pathway as a biomarker for donor lung assessment in clinical ex vivo lung perfusion.
Machuca TN; Cypel M; Zhao Y; Grasemann H; Tavasoli F; Yeung JC; Bonato R; Chen M; Zamel R; Chun YM; Guan Z; de Perrot M; Waddell TK; Liu M; Keshavjee S
J Heart Lung Transplant; 2015 Jun; 34(6):849-57. PubMed ID: 25907141
[TBL] [Abstract][Full Text] [Related]
25. Protein expression profiling predicts graft performance in clinical ex vivo lung perfusion.
Machuca TN; Cypel M; Yeung JC; Bonato R; Zamel R; Chen M; Azad S; Hsin MK; Saito T; Guan Z; Waddell TK; Liu M; Keshavjee S
Ann Surg; 2015 Mar; 261(3):591-7. PubMed ID: 25371129
[TBL] [Abstract][Full Text] [Related]
26. Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD).
Keller M; Bush E; Diamond JM; Shah P; Matthew J; Brown AW; Sun J; Timofte I; Kong H; Tunc I; Luikart H; Iacono A; Nathan SD; Khush KK; Orens J; Jang M; Agbor-Enoh S
J Heart Lung Transplant; 2021 Jun; 40(6):488-493. PubMed ID: 33814284
[TBL] [Abstract][Full Text] [Related]
27. Ex vivo lung perfusion to improve donor lung function and increase the number of organs available for transplantation.
Valenza F; Rosso L; Coppola S; Froio S; Palleschi A; Tosi D; Mendogni P; Salice V; Ruggeri GM; Fumagalli J; Villa A; Nosotti M; Santambrogio L; Gattinoni L
Transpl Int; 2014 Jun; 27(6):553-61. PubMed ID: 24628890
[TBL] [Abstract][Full Text] [Related]
28. Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation.
Shah RJ; Wickersham N; Lederer DJ; Palmer SM; Cantu E; Diamond JM; Kawut SM; Lama VN; Bhorade S; Crespo M; Demissie E; Sonett J; Wille K; Orens J; Weinacker A; Shah P; Arcasoy S; Wilkes DS; Christie JD; Ware LB;
Am J Transplant; 2014 Feb; 14(2):446-52. PubMed ID: 24400993
[TBL] [Abstract][Full Text] [Related]
29. Treatment with 3-aminobenzamide during ex vivo lung perfusion of damaged rat lungs reduces graft injury and dysfunction after transplantation.
Wang X; Parapanov R; Debonneville A; Wang Y; Abdelnour-Berchtold E; Gonzalez M; Gronchi F; Perentes JY; Ris HB; Eckert P; Piquilloud L; Lugrin J; Letovanec I; Krueger T; Liaudet L
Am J Transplant; 2020 Apr; 20(4):967-976. PubMed ID: 31710417
[TBL] [Abstract][Full Text] [Related]
30. Plasma protein biomarkers for primary graft dysfunction after lung transplantation: a single-center cohort analysis.
Chacon-Alberty L; Kanchi RS; Ye S; Hochman-Mendez C; Daoud D; Coarfa C; Li M; Grimm SL; Baz M; Rosas I; Loor G
Sci Rep; 2022 Sep; 12(1):16137. PubMed ID: 36167867
[TBL] [Abstract][Full Text] [Related]
31. Endothelial Glycocalyx Shedding Predicts Donor Organ Acceptability and Is Associated With Primary Graft Dysfunction in Lung Transplant Recipients.
Sladden TM; Yerkovich S; Grant M; Zhang F; Liu X; Trotter M; Hopkins P; Linhardt RJ; Chambers DC
Transplantation; 2019 Jun; 103(6):1277-1285. PubMed ID: 30444804
[TBL] [Abstract][Full Text] [Related]
32. Single-center experience of ex vivo lung perfusion and subsequent lung transplantation.
Noda K; Chan EG; Furukawa M; Ryan JP; Clifford S; Luketich JD; Sanchez PG;
Clin Transplant; 2023 Feb; 37(2):e14901. PubMed ID: 36588340
[TBL] [Abstract][Full Text] [Related]
33. Soluble p-selectin and the risk of primary graft dysfunction after lung transplantation.
Kawut SM; Okun J; Shimbo D; Lederer DJ; De Andrade J; Lama V; Shah A; Milstone A; Ware LB; Weinacker A; Demissie E; Christie JD;
Chest; 2009 Jul; 136(1):237-244. PubMed ID: 19255296
[TBL] [Abstract][Full Text] [Related]
34. Common Criteria for Ex Vivo Lung Perfusion Have No Significant Impact on Posttransplant Outcomes.
Okahara S; Levvey B; McDonald M; D'Costa R; Opdam H; Pilcher DV; Snell GI
Ann Thorac Surg; 2021 Apr; 111(4):1156-1163. PubMed ID: 32890490
[TBL] [Abstract][Full Text] [Related]
35. Early protein expression profile in bronchoalveolar lavage fluid and clinical outcomes in primary graft dysfunction after lung transplantation.
Frick AE; Verleden SE; Ordies S; Sacreas A; Vos R; Verleden GM; Vanaudenaerde BM; Claes S; Schols D; Van Raemdonck DE; Neyrinck AP
Eur J Cardiothorac Surg; 2020 Aug; 58(2):379-388. PubMed ID: 32267918
[TBL] [Abstract][Full Text] [Related]
36. The impact and relevance of techniques and fluids on lung injury in machine perfusion of lungs.
Ponholzer F; Dumfarth J; Krapf C; Pircher A; Hautz T; Wolf D; Augustin F; Schneeberger S
Front Immunol; 2024; 15():1358153. PubMed ID: 38510260
[TBL] [Abstract][Full Text] [Related]
37. Pretransplant dyslipidaemia influences primary graft dysfunction after lung transplantation.
Cottini SR; Ehlers UE; Pagnamenta A; Brandi G; Weder W; Schuepbach RA; Béchir M; Benden C
Interact Cardiovasc Thorac Surg; 2016 Apr; 22(4):402-5. PubMed ID: 26718318
[TBL] [Abstract][Full Text] [Related]
38. Primary Graft Dysfunction.
Natalini JG; Diamond JM
Semin Respir Crit Care Med; 2021 Jun; 42(3):368-379. PubMed ID: 34030200
[TBL] [Abstract][Full Text] [Related]
39. Extracorporeal membrane oxygenation for grade 3 primary graft dysfunction after lung transplantation: Long-term outcomes.
Bellier J; Lhommet P; Bonnette P; Puyo P; Le Guen M; Roux A; Parquin F; Chapelier A; Sage E;
Clin Transplant; 2019 Mar; 33(3):e13480. PubMed ID: 30657612
[TBL] [Abstract][Full Text] [Related]
40. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
Cypel M; Feld JJ; Galasso M; Pinto Ribeiro RV; Marks N; Kuczynski M; Kumar D; Bahinskaya I; Bagnato VS; Kurachi C; Slutsky AS; Yeung JC; Donahoe L; de Perrot M; Yasufuku K; Pierre A; Binnie M; Chaparro C; Martinu T; Chen M; Tikkanen J; Chow CW; Sidhu A; Waddell TK; Keshavjee S; Singer LG; Humar A
Lancet Respir Med; 2020 Feb; 8(2):192-201. PubMed ID: 31606437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
